Clear the fog, draw up a clear vaccination policy

#GS2 #GOVERNANCE #GS3 #COVID-19

India’s COVID-19 control plan of actions can be the nucleus for building a much-needed public health infrastructure.

  • Vaccines play a major role in human mastery over infectious diseases. Vaccine can induce immunity only in the vaccinated individual. 
  • So, vaccination is ‘preventive medicine’. When a vaccine is rolled out as a national or global programme and increasing proportions of people are vaccinated, ‘herd immunity’ level increases and disease frequency decreases in the vaccinated population. 

 

Disease burden and control

  • In epidemiology, the common word control has a specific meaning: ‘deliberate reduction of disease frequency to a desired level, validated with evidence’. 
  • The extreme form of control is ‘elimination’ of transmission of the microbe in a whole country. 
  • The hierarchy of human mastery over infectious microbes using vaccines ranges from individual protection and community control, to elimination and eradication.
  • So far, smallpox and cattle plague have been eradicated using their respective vaccines. Severe Acute Respiratory Syndrome (SARS) was eradicated in 2003 without a vaccine, using ‘non-pharmacological interventions’, or NPI, systematic case detection, contact tracing and quarantine. 
  • Success was possible because virus transmission occurred only after individuals developed fever. 
  • History of travel from affected countries and fever-screening identified potentially infectious persons who were quarantined for breaking transmission chains. 
  • So, we cannot stop transmission; but with NPI (face masks, hand hygiene and avoiding crowds), we can retard transmission.

 

Vaccine candidates and India

  • Three COVID-19 vaccines have claims of about 90-95% protective efficacy — BNT162b2 (Pfizer-BioNTech), mRNA-1273 (Moderna) and Sputnik-V (Gamaleya Institute). 
  • Hopefully they will soon get registration for general use in their respective countries of origin. 
  • ChAdOx1 nCoV-19 (Oxford-AstraZeneca), manufactured under licence by Serum Institute of India as Covishield, is undergoing phase 2-phase 3 trials in India. 
  • The likelihood of Sputnik-V getting registration in India is probably high, possibly before end-2020. 
  • An indigenous vaccine candidate, Covaxin (Bharat Biotech), found safe and immunogenic in phase 1 and phase 2 trials, is now under phase 3 trial. 
  • In India’s national Universal Immunisation Programme (UIP), policy is defined, vaccines procured and supplied by the Union government and vaccination implemented by State governments. 
  • So, policy development is the function of the central government — States must implement the action plan emerging from policy. 
  • States have the freedom to surpass policy limits if no fund is sought. 

 

Unanswered policy issues

  • Fortunately, the three front running vaccines for India — Sputnik V, Covishield, Covaxin — need only the standard cold chain available to the UIP, except that any new vaccine will require significant additional cold chain space. 
  • All vaccines in the UIP are available in the private sector too. An important policy issue is whether vaccination should be confined to only uninfected individuals. 
  • All test results of infected subjects are available on a computer data base and that is one way to identify those who were already infected.
  • Many senior citizens are protected from exposure to infection by cocooning within homes. 
  • The vaccination stations should be staffed with trained personnel and supervised by medical doctors. 
  • The site must have a waiting area and a post-vaccination staying area to manage any untoward reaction during the first hour.
  • A computerised master list with details and mobile numbers of all vaccinated subjects needs to be maintained for the purpose of post-vaccination follow up to document rare side-effects. Data management has to be meticulously planned and executed.
  • The central and State governments in general and Health Departments in particular have a mammoth task ahead of them.
  • It is a big challenge to protect the life and the health of citizens, and also a huge opportunity to eliminate the novel coronavirus from India, setting an example to the rest of the world. With will and wisdom, we can, and should, accomplish this.
Print Friendly and PDF
blog comments powered by Disqus